Imaging of pulmonary hypertension: an update
#MMPMID30057876
Goerne H
; Batra K
; Rajiah P
Cardiovasc Diagn Ther
2018[Jun]; 8
(3
): 279-296
PMID30057876
show ga
Pulmonary hypertension (PH) is characterized by elevated pulmonary arterial
pressure caused by a broad spectrum of congenital and acquired disease processes,
which are currently divided into five groups based on the 2013 WHO
classification. Imaging plays an important role in the evaluation and management
of PH, including diagnosis, establishing etiology, quantification,
prognostication and assessment of response to therapy. Multiple imaging
modalities are available, including radiographs, computed tomography (CT),
magnetic resonance imaging (MRI), nuclear medicine, echocardiography and invasive
catheter angiography (ICA), each with their own advantages and disadvantages. In
this article, we review the comprehensive role of imaging in the evaluation of
PH.